Last update:
Medications news
Medications
Drug used to treat eczema may provide relief for patients with intensely itchy skin diseases
A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a study published in JAMA Dermatology.
12 hours ago
0
3
Medications
Study shows ivonescimab improves progression-free survival in EGFR+ lung cancer
For patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus chemotherapy improves progression-free survival, according to a study published online May 31 in the ...
5 hours ago
0
0
Study: Afib patients on low doses of blood thinners have more bleeding episodes than those on standard doses
Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes during the first three months of treatment and about ...
10 hours ago
0
0
One in six people who stop antidepressants will experience discontinuation symptoms as a direct result, says study
For someone stopping taking antidepressants, the risk of experiencing one or more discontinuation symptoms (also called withdrawal symptoms), such as dizziness, headache, nausea, insomnia and irritability due directly to ...
Jun 5, 2024
0
55
Oral insulin drops offer relief for diabetes patients
Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage the disease and maintain ...
Jun 5, 2024
0
27
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday—a potentially major setback to psychedelic advocates who hope to win a landmark federal approval ...
Jun 5, 2024
0
27
Researchers identify universal bitter blocker that could help patients take their life-saving medicines as prescribed
Many people, especially children and the elderly, have difficulty swallowing pills. Liquid forms of many medicines taste extremely bitter and are often rejected. Put simply, strong bitterness is the main reason why people ...
Jun 5, 2024
0
0
New study finds that both stimulant and non-stimulant medications improve cognition in ADHD
Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental disorders and can persist into adulthood in the majority of cases. ADHD is associated with deficits in cognitive functions, in ...
Jun 5, 2024
0
0
Could taking certain drugs reduce risk of ruptured brain aneurysm?
A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm. The study is published in the June 5, 2024, online issue of Neurology. The ...
Jun 5, 2024
0
2
Study shows crinecerfont aids patients with congenital adrenal hyperplasia
Crinecerfont results in a greater decrease from baseline in the mean daily glucocorticoid dose among patients with congenital adrenal hyperplasia (CAH), according to a study published June 2 in the New England Journal of ...
Jun 5, 2024
0
0
Study suggests that adding common bone loss drugs to azoles can improve efficacy when treating fungal infections
Human skin, hair and nails are all vulnerable to fungal infections. While these infections are usually not serious, they're difficult to fully resolve and often recur after treatment—sometimes for years. They're also often ...
Jun 5, 2024
0
0
An anti-inflammatory curbs spread of fungi causing serious blood infections
A team of UC Davis Health researchers has discovered that a common anti-inflammatory drug, mesalamine, can replace the work of good bacteria in fighting the nasty fungus Candida albicans in the gut.
Jun 4, 2024
0
26
Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns
Drugs like Ozempic, Wegovy and Mounjaro have been around for years, but they've recently been making headlines due to a rise in popularity as weight loss agents. They all belong to a class of drugs known as glucagon-like ...
Jun 4, 2024
0
46
New curative therapy brings hope for the treatment of nodding syndrome
A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.
Jun 4, 2024
0
43
US health officials advise using antibiotic as a 'morning-after pill' against STDs
Some people should consider taking an antibiotic as a morning-after pill to try to prevent certain sexually transmitted diseases, U.S. health officials recommended Tuesday.
Jun 4, 2024
0
1
How an Indian government policy backfired: The unintended consequences of price regulation of prescription drugs
Researchers from the Indian Institute of Management Calcutta, University of Chicago, and Management Development Institute, Gurgaon have published a new study that examines the unintended consequences of an Indian government ...
Jun 4, 2024
0
0
Leukemia drug passes final trial phase with flying colors
A medication to treat chronic myeloid leukemia (CML) has shown its potential to become the new frontline therapy for people living with the life-threatening blood cancer.
Jun 4, 2024
0
1
Prenatal supplements fall far short in crucial nutrition during pregnancy—most women don't even know it
If there's one thing doctors agree on, it's that all of their pregnant patients should take prenatal supplements. As a result, about 3 in 4 expecting mothers follow their doctor's advice.
Jun 4, 2024
0
0
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Federal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD—part of a decadeslong effort by psychedelic advocates to win medical acceptance for the drug's ...
Jun 4, 2024
0
1
FDA approves first liquid, nonstimulant ADHD treatment
The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).
Jun 4, 2024
0
3
